Share This

Public company info - Wuxi Biologics (Cayman) Inc. , 02269.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Wuxi Biologics (Cayman) Inc., 02269.HK - Profit Loss 2023-12 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12
Turnover 17,034,255 15,268,660 10,290,050 5,612,384 3,983,687 2,534,453 1,618,829 989,029 557,042 331,850
Operating Profit 4,173,803 5,357,771 3,993,119 1,963,128 1,129,752 737,722 303,687 175,846 65,402 49,012
Exceptional Items 0 0 0 0 0 0 0 0 0 0
Associates 0 0 0 2,632 -3,119 0 0 0 0 0
Profit Before Taxation 4,173,803 5,357,771 3,993,119 1,965,760 1,126,633 737,722 303,687 175,846 65,402 49,012
Taxation 603,179 807,865 484,538 273,066 116,296 107,257 51,059 34,750 20,893 7,034
Minority Interests 170,895 129,620 120,103 3,808 -3,468 -127 0 0 0 0
Net Profit 3,399,729 4,420,286 3,388,478 1,688,886 1,013,805 630,592 252,628 141,096 44,509 41,978
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Major Items
Depreciation 1,385,662 1,042,990 703,098 459,037 335,951 222,112 122,748 93,185 57,006 42,309
Interest Paid 232,195 124,181 103,227 86,421 24,961 0 36,768 30,449 2,531 2,556
Interest Capitalized 73,707 59,799 64,036 43,689 5,356 0 1,077 6,294 0 0
Non-current Assets Revaluation / Disposal 0 0 0 0 0 0 0 0 0 0
Taxation Rate (%) 14.45 15.08 12.13 13.89 10.32 14.54 16.81 19.76 31.95 14.35
Turnover Growth (%) 11.56 48.38 83.35 40.88 57.18 56.56 63.68 77.55 67.86 0.0
Net Profit Growth (%) -23.09 30.45 100.63 66.59 60.77 149.61 79.05 217.01 6.03 0.0
Auditor's Opinion 0 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.